PIRO, SALVATORE
 Distribuzione geografica
Continente #
NA - Nord America 7.762
EU - Europa 3.823
AS - Asia 2.863
SA - Sud America 735
AF - Africa 579
OC - Oceania 8
Continente sconosciuto - Info sul continente non disponibili 6
Totale 15.776
Nazione #
US - Stati Uniti d'America 7.501
IT - Italia 1.488
SG - Singapore 1.470
IE - Irlanda 911
CN - Cina 819
BR - Brasile 678
UA - Ucraina 582
CI - Costa d'Avorio 356
CA - Canada 242
IN - India 240
RU - Federazione Russa 208
SN - Senegal 151
DE - Germania 150
SE - Svezia 142
VN - Vietnam 87
GB - Regno Unito 72
FI - Finlandia 54
FR - Francia 41
TR - Turchia 41
KR - Corea 35
UZ - Uzbekistan 35
NG - Nigeria 33
NL - Olanda 32
AT - Austria 30
CH - Svizzera 24
BD - Bangladesh 20
HK - Hong Kong 20
AR - Argentina 19
JP - Giappone 16
PL - Polonia 15
IQ - Iraq 14
LB - Libano 14
MA - Marocco 14
PK - Pakistan 13
GR - Grecia 12
EC - Ecuador 10
MX - Messico 10
BG - Bulgaria 9
CZ - Repubblica Ceca 9
ES - Italia 9
ZA - Sudafrica 9
BE - Belgio 8
KE - Kenya 8
AU - Australia 6
EU - Europa 6
IR - Iran 6
PY - Paraguay 6
SA - Arabia Saudita 6
VE - Venezuela 6
CO - Colombia 5
AL - Albania 4
AZ - Azerbaigian 4
CL - Cile 4
DO - Repubblica Dominicana 4
RO - Romania 4
BO - Bolivia 3
KG - Kirghizistan 3
LT - Lituania 3
GE - Georgia 2
HU - Ungheria 2
ID - Indonesia 2
IS - Islanda 2
JO - Giordania 2
KW - Kuwait 2
MK - Macedonia 2
NZ - Nuova Zelanda 2
RS - Serbia 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
SV - El Salvador 2
TN - Tunisia 2
UY - Uruguay 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
BB - Barbados 1
BH - Bahrain 1
BN - Brunei Darussalam 1
EE - Estonia 1
ET - Etiopia 1
GA - Gabon 1
GL - Groenlandia 1
GY - Guiana 1
IL - Israele 1
KZ - Kazakistan 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MN - Mongolia 1
MY - Malesia 1
NP - Nepal 1
OM - Oman 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
TG - Togo 1
TW - Taiwan 1
TZ - Tanzania 1
Totale 15.776
Città #
Santa Clara 1.295
Chandler 1.025
Dublin 910
Singapore 869
Jacksonville 645
Chicago 435
Boardman 363
Abidjan 356
Catania 256
Cambridge 247
Lawrence 246
Andover 245
Nanjing 216
Civitanova Marche 203
Kochi 189
Ashburn 188
Toronto 182
Wilmington 159
Dakar 151
Milan 134
Des Moines 133
Rome 127
San Mateo 95
Hefei 69
Houston 66
Padova 64
Dong Ket 63
Nanchang 63
Beijing 62
The Dalles 62
Shenyang 60
Bremen 55
Hebei 53
Columbus 47
Los Angeles 46
Ottawa 44
Saint Petersburg 44
Council Bluffs 42
Munich 39
São Paulo 39
Jiaxing 38
Changsha 36
Palermo 36
Seoul 34
Abuja 32
New York 27
Belo Horizonte 24
Moscow 24
San Francisco 24
Seattle 24
Tianjin 24
Lappeenranta 23
Carrara 22
Messina 21
Boydton 19
Istanbul 19
Helsinki 18
Washington 18
Hong Kong 17
Rio de Janeiro 17
Pune 16
Hanoi 15
Tokyo 15
Brasília 14
Tashkent 14
Turku 13
Augusta 12
Brooklyn 12
Jinan 11
Naples 11
Norwalk 11
Phoenix 11
Bari 10
Dallas 10
Den Haag 10
Dhaka 10
Stockholm 10
Boston 9
Genoa 9
Leawood 9
Reggio Emilia 9
Salvador 9
Taizhou 9
Woodbridge 9
Ann Arbor 8
Cascina 8
Gravina di Catania 8
Guangzhou 8
London 8
Mumbai 8
Nairobi 8
Porto Alegre 8
Vienna 8
Warsaw 8
Campo Grande 7
Edinburgh 7
Falls Church 7
Grafing 7
Hangzhou 7
Mountain View 7
Totale 10.474
Nome #
IL DIABETE MELLITO AUMENTA LE RESISTENZE ARTERIOSE RENALI NEI PAZIENTI CON CIRROSI EPATICA 689
1 h Postload Glycemia Is Associated with Low Endogenous Secretory Receptor for Advanced Glycation End Product Levels and Early Markers of Cardiovascular Disease 155
Adherence to antithrombotic therapy guidelines improves mortality among elderly patients with atrial fibrillation: insights from the REPOSI study 134
Controlling Nutritional Status (CONUT) Score as a Potential Prognostic Indicator of In-Hospital Mortality, Sepsis and Length of Stay in an Internal Medicine Department 107
Polypharmacy in older people: lessons from 10 years of experience with the REPOSI register 105
Chronic exposure to palmitate impairs insulin signaling in an intestinal L-cell line: A possible shift from GLP-1 to glucagon production 105
HbA1c identifies subjects with prediabetes and subclinical left ventricular diastolic dysfunction 100
Analysis of S100A12 plasma levels in hyperlipidemic subjects with or without familial hypercholesterolemia 98
The impact of SLCO1B1 rs4149056 on LDL-C target achievement after lipid lowering therapy optimization in men and women with familial hypercholesterolemia 96
Antibiotic use and associated factors in a large sample of hospitalised older people 95
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 93
Separate impact of metabolic syndrome and altered glucose tolerance on early markers of vascular injuries. 92
Analysis of HDL-microRNA panel in heterozygous familial hypercholesterolemia subjects with LDL receptor null or defective mutation 92
A local glucagon-like peptide 1 (GLP-1) system in human pancreatic islets 90
Choice and Outcomes of Rate Control versus Rhythm Control in Elderly Patients with Atrial Fibrillation: A Report from the REPOSI Study 90
An Uncharacterised lncRNA Coded by the ASAP1 Locus Is Downregulated in Serum of Type 2 Diabetes Mellitus Patients 89
Atorvastatin but not pravastatin impairs mitochondrial function in human pancreatic islets and rat β-cells. Direct effect of oxidative stress 89
Arterial stiffness improvement after adding on PCSK9 inhibitors or ezetimibe to high-intensity statins in patients with familial hypercholesterolemia: A Two-Lipid Center Real-World Experience 89
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritisation and Network Analysis of New Candidate Genes from the Apoptotic Machinery 88
Prevalence and Determinants of the Use of Lipid-Lowering Agents in a Population of Older Hospitalized Patients: the Findings from the REPOSI (REgistro POliterapie Società Italiana di Medicina Interna) Study 88
Hospital Care of Older Patients With COPD: Adherence to International Guidelines for Use of Inhaled Bronchodilators and Corticosteroids 88
Trattamento dell’ipercolesterolemia nel soggetto con diabete mellito: Aggiornamento sugli approcci terapeutici 86
Early phase insulin secretion is increased in subjects with normal fasting glucose and metabolic syndrome: a premature feature of beta-cell dysfunction 85
Funzione mitocondriale in isole pancreatiche di pazienti con diabete tipo 2 85
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritization and Network Analysis of New Candidate Genes from the Apoptotic Machinery 84
Chronic Exposure to GLP-1 Increases GLP-1 Synthesis and Release in a Pancreatic Alpha Cell Line (α-TC1): Evidence of a Direct Effect of GLP-1 on Pancreatic Alpha Cells 83
L’induzione di apoptosi da parte di protoni suggerisce innovative strategie terapeutiche anticancro 82
Alpha- and beta-cell abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 82
Implementation of the Frailty Index in hospitalized older patients: Results from the REPOSI register 82
Effetti della glucotossicita' su una linea cellulare di L cellule intestinali (GLUTAg: Ruolo di UCP-2 81
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritization and Network Analysis of New Candidate Genes from the Apoptotic Machinery 81
Cellular and molecular effects of protons: Apoptosis induction and potential implications for cancer therapy 81
Adherence to antibiotic treatment guidelines and outcomes in the hospitalized elderly with different types of pneumonia 81
Inflammation and ventricular-vascular coupling in hypertensive patients with metabolic syndrome 81
Candidate genes of SARS-CoV-2 gender susceptibility 81
Cardiovascular Risk Profile in Subjects With Prediabetes and New-Onset Type 2 Diabetes Identified by HbA1c According to American Diabetes Association Criteria 80
Mortality rate and risk factors for gastrointestinal bleeding in elderly patients 80
High intake of dietary advanced glycation end-products is associated with increased arterial stiffness and inflammation in subjects with type 2 diabetes 79
Alterazioni lipidiche ed epatiche in soggetti con prediabete identificato in base all'emoglobina glicosilata 79
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 79
Analysis of steatosis biomarkers and inflammatory profile after adding on PCSK9 inhibitor treatment in familial hypercholesterolemia subjects with nonalcoholic fatty liver disease: a single lipid center real-world experience 79
(2012). Specifically different microRNAs profiles provide new insights on the molecular mechanisms activated by cytotoxic proinflammatory cytokines in mammalian pancreatic alpha and beta cells 78
Altered expression of uncoupling protein 2 in GLP-1-producing cells after chronic high glucose exposure: implications for the pathogenesis of diabetes mellitus. 78
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 78
Role of ATP Production and Uncoupling Protein-2 in the Insulin Secretory Defect Induced by Chronic Exposure to High Glucose or Free Fatty Acids and Effects of Peroxisome Proliferator-Activated Receptor-gamma Inhibition 77
LONG NON-CODING RNA ASSOCIATI AL DIABETE MELLITO. FOCUS SULLE COMPLICANZE MICRO E MACROVASCOLARI 77
Pathophysiological, Molecular and Therapeutic Issues of Nonalcoholic Fatty Liver Disease: An Overview 77
Impaired Glucagon Suppression And Reduced Insulin Sensitivity In Subjects With Prediabetes Undergoing Atorvastatin Therapy 77
Circulating coding and long non-coding rnas as potential biomarkers of idiopathic pulmonary fibrosis 77
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritization and Network Analysis of New Candidate Genes from the Apoptotic Machinery 76
Glucagon as a therapeutic approach to severe hypoglycemia: After 100 years, is it still the antidote of insulin? 76
Heart failure and chronic kidney disease in a registry of internal medicine wards 76
High glomerular filtration rate is associated with impaired arterial stiffness and subendocardial viability ratio in prediabetic subjects 76
Effect of PCSK9 inhibitors on pulse wave velocity and monocyte-to-HDL-cholesterol ratio in familial hypercholesterolemia subjects: results from a single-lipid-unit real-life setting 76
New treatment options for lipid-lowering therapy in subjects with type 2 diabetes 75
Chronic exposure to high leucine impairs glucose-induced insulin release by lowering the ATP to ADP ratio 74
A Molecular Systems BioMedicine Approach to Diabetes: Characterization, Prioritisation and Network Analysis of New Candidate Genes from the Apoptotic Machinery (AM) 73
Acidi grassi polinsaturi omega 3 (PUFA): studio pilota nella terapia della NAFDL 73
An increased waist-to-hip ratio is a key determinant of atherosclerotic burden in overweight subjects 73
Functional and morphological alterations of mitochondria in pancreatic beta cells from type 2 diabetic patients 71
Metformin restores insulin secretion altered by chronic exposure to free fatty acids or high glucose: a direct metformin effect on pancreatic beta cells 71
Chronic exposure to palmitate affects insulin signaling in pancreatic alpha cells 71
296-3p, miR-298-5p and their downstream networks are causally involved in the higher resistance of mammalian pancreatic α cells to cytokine-induced apoptosis as compared to β cells 71
Acidi grassi polinsaturi omega 3 (PUFA): studio pilota nella terapia della NAFLD 71
Clinical and molecular biomarkers for diagnosis and staging of nafld 71
Direct and indirect effects of sars-cov-2 pandemic in subjects with familial hypercholesterolemia: A single lipid-center real-world evaluation 71
Low advanced glycation end product diet improves the lipid and inflammatory profiles of prediabetic subjects 70
Type 2 diabetes susceptibility gene expression in normal or diabetic sorted human alpha and beta cells: correlations with age or BMI of islet donors 70
Update on Diabetic Kidney Disease (DKD): Focus on Non-Albuminuric DKD and Cardiovascular Risk 69
Role of ATP production and uncoupling protein 2 in the insulin secretory defect induced by chronic exposure to high glucose or free fatty acids 69
Lipid and liver abnormalities in haemoglobin A1c-defined prediabetes and type 2 diabetes 69
Il GLP-1 migliora il segnale insulinico intracellulare in una linea di alfa cellule pancreatiche murine (a-TC1-6) 69
miR-296-3p, miR-298-5p and their downstream networks are causally involved in the higher resistance of mammalian pancreatic α cells to cytokine-induced apoptosis as compared to β cells 68
Serum coding and non-coding RNAs as biomarkers of NAFLD and fibrosis severity 68
L'emoglobina Glicosilata potrebbe identificare soggetti con normale tolleranza al glucosio ma con alterazione dei markers precoci di danno cardiovascolare. 67
Alterazioni molecolari del segnale insulinico e del metabolismo degli FFA in pazienti con NASH 67
A molecular systems biomedicine approach to Diabetes: characterization, prioritization and network analysis of new candidate genes from the apoptotic machinery 67
Thyroid Cancer and Circadian Clock Disruption 67
Cardiovascular risk and renal injury profile in subjects with type 2 diabetes and non-albuminuric diabetic kidney disease 66
Intracellular and extracellular miRNome deregulation in cellular models of NAFLD or NASH: Clinical implications 66
Molecular Effects of Chronic Exposure to Palmitate in Intestinal Organoids: A New Model to Study Obesity and Diabetes 65
Exposure to glibenclamide increases rat beta cell sensitivity to glucose 65
La lipotossicità peggiora il segnale insulinico intracellulare in una linea di L-cellule intestinali murine (GLUTag) 65
Direct effects of d-chiro-inositol on insulin signaling and glucagon secretion of pancreatic alpha cells 65
Appropriateness of antiplatelet therapy for primary and secondary cardio- and cerebrovascular prevention in acutely hospitalized older people 64
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 64
• Effect of metabolic sindrome and altered glucose tolerance on distolic cardiac function and intima-media thickness.• Effect of metabolic sindrome and altered glucose tolerance on distolic cardiac function and intima-media thickness 63
Gli incretinomimetici e gli inibitori del DPP-IV 63
Prophylaxis of venous thromboembolism in elderly patients with multimorbidity. 63
Insulin secretory function is impaired in isolated human islets carrying the Gly972-Arg IRS-1 polymorphism 63
Prediabete: Criteri diagnostici e rischio cardiovascolare 63
High TG to HDL ratio plays a significant role on atherosclerosis extension in prediabetes and newly diagnosed type 2 diabetes subjects 63
Deregolazione del miRNoma intracellulare ed extracellulare ed analisi bioinformatica in modelli in vitro di NAFLD e NASH 62
Therapeutic options for elderly diabetic subjects: open label, randomized clinical trial of insulin glargine added to oral antidiabetic drugs versus increased dosage of oral antidiabetic drugs 62
Drug–drug interactions involving CYP3A4 and p-glycoprotein in hospitalized elderly patients 62
Coffee Restores Expression of lncRNAs Involved in Steatosis and Fibrosis in a Mouse Model of NAFLD 62
Long-term benefits of dapagliflozin on renal outcomes of type 2 diabetes under routine care: a comparative effectiveness study on propensity score matched cohorts at low renal risk 61
Direct apoptotic effects of free fatty acids on human endothelial cells 61
Low circulating vitamin D levels are associated with increased arterial stiffness in prediabetic subjects identified according to HbA1c 61
Soggetti obesi insulino- resistenti con elevato rischio per diabete tipo 2 mostrano disfunzione alfa- cellulare ed alterata secrezione di GLP-1 comparati a individui obesi metabolicamenti sani 61
Totale 8.377
Categoria #
all - tutte 63.208
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 63.208


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.254 12 106 139 20 328 37 155 9 96 91 156 105
2021/20221.861 190 257 9 37 314 55 272 71 146 9 61 440
2022/20233.094 262 156 47 313 281 511 10 601 718 19 112 64
2023/20241.465 68 236 74 72 68 313 48 133 17 38 227 171
2024/20256.570 697 863 326 421 1.183 646 242 221 378 543 639 411
2025/2026278 278 0 0 0 0 0 0 0 0 0 0 0
Totale 16.229